BioSpace News Archive

European Medicines Agency Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for Review

HD201 is Prestige’s lead development candidate biosimilar to Herceptin, which is indicated for the treatment of adult patients with HER2-overexpressing breast cancer as well as HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

May 29, 2019
·
2 min read
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting

Participating shareholders represented a total of 4’109’097 shares or 36.8% of the share capital.

May 29, 2019
·
4 min read
Deals

Golden Gate Capital Invests in Ensemble Health Partners - May 29, 2019

Ensemble Health Partners announced that Bon Secours Mercy Health will sell 51 percent of the equity in Ensemble to Golden Gate Capital, a leading private equity investment firm.

May 29, 2019
·
6 min read
Business

BioData celebrates successful Q1 customer growth

BioData reports a successful Q1 following further adoption of its flagship Electronic Lab Notebook product - Labguru.

May 29, 2019
·
3 min read
Biotech Bay

Loop Genomics launches four new Microbiome kits leveraging their ability to perform long-reads on Illumina sequencers

Loop Genomics deploys new sequencing technology and protocols to provide unparalleled insight into microbiome research

May 29, 2019
·
2 min read
DeepMass: A new machine learning method for the characterization of proteins

The presence and levels of certain proteins in our bodies, known as protein profiles, provide a direct, up-to-date window into the status of our health.

May 29, 2019
·
3 min read
Pharm Country

Certara Introduces Integral, its Next-generation Data Repository

It is a multi-functional, cloud-based, 21 CFR Part 11 compliant platform for clinical pharmacology, pharmacometrics and clinical operations professionals

May 29, 2019
·
3 min read
BioMidwest

First study to see if de-prescribing commonly used drug class prevents or delays dementia

Regenstrief researcher receives $3.3 million NIA award for cause and effect study

May 29, 2019
·
3 min read
BOC Sciences to Launch Chemical Building Block Synthesis for Drug Discovery

To conduct this new business, various synthesis methods and techniques are required.

May 29, 2019
·
2 min read
Business

Sygnature Discovery and RenaSci strengthen in vivo pharmacology service-offering

Dr Moore is an internationally recognised drug discovery and development specialist who has spent nearly 40 years working in the field of in vivo pharmacology.

May 29, 2019
·
3 min read